Papers/PMID:32810309
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
Journal of gastroenterology and hepatology2021The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
α-tocopherol — decreases alanine aminotransferase
Evidence strength: very limited.Findingreplicated ×4“Vitamin E reduced the values of liver enzymes compared with placebo (-7.37 IU/L, 95% confidence interval: -10.11 to -4.64 for alanine aminotransferase, and -5.71 IU/L, 95% confidence interval: -9.49 to -1.93 for aspartate aminotransferase).”
Quoted verbatim from Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.. - Study
- meta-analysis
- Population
- Adults with non-alcoholic fatty liver disease in randomized trials of vitamin E versus placebo
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.2021PMID:3281030910.1111/jgh.15221Permalink
α-tocopherol — decreases aspartate aminotransferase
Evidence strength: very limited.Findingreplicated ×4“Vitamin E reduced the values of liver enzymes compared with placebo (-7.37 IU/L, 95% confidence interval: -10.11 to -4.64 for alanine aminotransferase, and -5.71 IU/L, 95% confidence interval: -9.49 to -1.93 for aspartate aminotransferase).”
Quoted verbatim from Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.. - Study
- meta-analysis
- Population
- Adults with non-alcoholic fatty liver disease in randomized trials of vitamin E versus placebo
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.2021PMID:3281030910.1111/jgh.15221Permalink